A new CRISPR-Cas9 approach that targets a detrimental signaling pathway in the heart confers protection from ischemia/reperfusion injury, according to a study in mice. The findings suggest that gene editing could offer a permanent and advanced strategy for treating heart disease – the leading cause of worldwide morbidity and mortality – and even serve as an intervention to repair cardiac damage immediately after a heart attack. CRISPR-Cas9 gene editing has shown promise as a therapeutic approach to treating rare hereditary diseases.

https://www.news-medical.net/news/20230112/New-CRISPR-Cas9-approach-confers-protection-from-ischemiareperfusion-injury.aspx

منبع: گروه علوم بیومدیکال مقایسه ای